The pharmacokinetic properties of beta adrenoceptor blocking drugs
- PMID: 6106455
Item in Clipboard
The pharmacokinetic properties of beta adrenoceptor blocking drugs
Arch Int Pharmacodyn Ther.
1980.
No abstract available
Similar articles
-
Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.Cardiology. 1979;64 Suppl 1:1-13. Cardiology. 1979. PMID: 42483 No abstract available.
-
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.Drugs. 1974;7(1):39-47. doi: 10.2165/00003495-197407010-00003. Drugs. 1974. PMID: 4151694 Review. No abstract available.
-
[Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].Herz. 1982 Jun;7(3):168-78. Herz. 1982. PMID: 6124492 German.
-
Beta blockers 1984. Part 1.Aust Fam Physician. 1984 Jul;13(7):533-4, 536, 538. Aust Fam Physician. 1984. PMID: 6148926 No abstract available.
-
Pharmacokinetic comparison of beta-adrenoceptor blocking agents.Clin Invest Med. 1978;1(3-4):135-8. Clin Invest Med. 1978. PMID: 42503 Review. No abstract available.
Cited by
-
Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.Br J Clin Pharmacol. 1982;13(Suppl 2):187S-192S. doi: 10.1111/j.1365-2125.1982.tb01909.x. Br J Clin Pharmacol. 1982. PMID: 6125169 Free PMC article. Review.